FBXO24 and pneumonia: While FBXO24 immunosuppressive activity may be detrimental to pathogen clearance at early stages of infection, it may also protect against collateral tissue damage and aid in the resolution of inflammation in pneumonia similar to the purported functions of lipid mediators and interleukin 1039,40.